not too bad - sales slightly down (have got rid of non core) div for Year up @ 5c so 5.88% at current price tax free (F F) basically.. Better than banks.Probably worth $1 (5% FF)?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%